2. Search Result
Search Result
Results for "

delivery vehicle

" in MedChemExpress (MCE) Product Catalog:

45

Inhibitors & Agonists

22

Biochemical Assay Reagents

4

Peptides

9

Isotope-Labeled Compounds

24

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-139413
    β-D-Glucan

    		Toll-like Receptor (TLR) Cancer
    β-D-glucan is a natural non-digestible polysaccharide and high biocompatibility that can be selectively recognized by recognition receptors such as Dectin-1 and Toll-like receptors as well as being easily internalized by murine or human macrophages, which is likely to attribute to a target delivery . β-d-glucan is an enteric delivery vehicle for probiotics .
    β-D-Glucan
  • HY-151509
    A2-Iso5-2DC18

    		Others Cancer
    A2-Iso5-2DC18 is a dihydroimidazole-linked lipid, served as potent mRNA delivery vehicle. A2-Iso5-2DC18 can be used for antitumor research, including B16F10 melanoma. .
    A2-Iso5-2DC18
  • HY-112251
    D-Lin-MC3-DMA
    Maximum Cited Publications
    65 Publications Verification

    		 Liposome Cancer
    D-Lin-MC3-DMA, an ionizable cationic lipid, is a potent siRNA delivery vehicle.
    D-Lin-MC3-DMA
  • HY-101103
    HP-β-CD
    10+ Cited Publications

    (2-Hydroxypropyl)-β-cyclodextrin

    		 Biochemical Assay Reagents Cancer
    HP-β-CD ((2-Hydroxypropyl)-β-cyclodextrin) is a widely used drug delivery vehicle to improve the stability and bioavailability.
    HP-β-CD
  • HY-145782
    Witepsol

    		Liposome Metabolic Disease
    Witepsol is a selective lipid-based vehicle for use in drug delivery systems .
    Witepsol
  • HY-142987
    Linoleyl methane sulfonate

    		Liposome Metabolic Disease
    Linoleyl methane sulfonate is a selective lipid-based vehicle for use in drug delivery systems .
    Linoleyl methane sulfonate
  • HY-P4117
    Penetratin-Arg

    		Bacterial Inflammation/Immunology
    Penetratin-Arg is an antimicrobial and is used for drug delivery vehicle .
    Penetratin-Arg
  • HY-112251A
    D-Lin-MC3-DMA (Excipient)

    		Liposome Cancer
    D-Lin-MC3-DMA Excipient, an ionizable cationic lipid, is a potent siRNA delivery vehicle.
    D-Lin-MC3-DMA (Excipient)
  • HY-112251S
    D-Lin-MC3-DMA-13C3

    		Isotope-Labeled Compounds Others
    D-Lin-MC3-DMA- 13C3 is the 13C labeled D-Lin-MC3-DMA. D-Lin-MC3-DMA, an ionizable cationic lipid, is a potent siRNA delivery vehicle[1][2].
    D-Lin-MC3-DMA-13C3
  • HY-151511
    A12-Iso5-2DC18

    		Liposome Cancer
    A12-Iso5-2DC18, an ionizable cationic lipid, is a potent mRNA delivery lipid vehicle .
    A12-Iso5-2DC18
  • HY-W090151
    Silyl-ether based ROMP monomer iPrSi

    		Biochemical Assay Reagents Others
    Silyl-ether based ROMP monomer iPrSi is a biochemical reagent that can be used in the synthesis of advanced polymer materials for biomedical applications, including drug delivery vehicles and hydrogels .
    Silyl-ether based ROMP monomer iPrSi
  • HY-W440727
    Cholesterol-PEG-Vinylsulfone (MW 2000)

    		Liposome Cancer
    Cholesterol-PEG-Vinylsulfone (MW 2000) is a thiol reactive polyPEG via thiol-ene reaction to form a thioether bond. It can self-assemble in water and is used to prepare liposome as drug vehicle for targeted delivery into tissues.
    Cholesterol-PEG-Vinylsulfone (MW 2000)
  • HY-158820
    Cosdosiran

    QPI-1007

    		 Small Interfering RNA (siRNA) Caspase Cardiovascular Disease
    Cosdosiran is a chemically modified siRNA designed to temporarily inhibit expression of the caspase 2 protein and can be used for the study of nonarteritic anterior ischemic optic neuropathy and other optic neuropathies such as glaucoma that result in the death of retinal ganglion cells.?
    Cosdosiran
  • HY-158820A
    Cosdosiran sodium

    QPI-1007 sodium

    		 Small Interfering RNA (siRNA) Caspase Cardiovascular Disease
    Cosdosiran sodium is a chemically modified siRNA designed to temporarily inhibit expression of the caspase 2 protein and can be used for the study of nonarteritic anterior ischemic optic neuropathy and other optic neuropathies such as glaucoma that result in the death of retinal ganglion cells.?
    Cosdosiran sodium
  • HY-E70364
    IgdE protease

    		Biochemical Assay Reagents Inflammation/Immunology
    IgdE protease is a cysteine protease, which is initially isolated from Streptococcus agalactiae. IgdE protease digests monoclonal antibodies (mAbs) of the IgG1 type specifically at their upper hinge region, produces Fc/2, hinge peptide dimers, and Fab fragment. IgdE protease can be used in disulfide bonds and free thiol analysis, as it requires no reducing agents for cleavage .
    IgdE protease
  • HY-138170
    ALC-0315
    10+ Cited Publications

    		 Liposome SARS-CoV Infection
    ALC-0315 is an ionisable aminolipid that is responsible for mRNA compaction and aids mRNA cellular delivery and its cytoplasmic release through suspected endosomal destabilization. ALC-0315 can be used to form lipid nanoparticle (LNP) delivery vehicles. Lipid-Nanoparticles have been used in the research of mRNA COVID-19 vaccine .
    ALC-0315
  • HY-109506S5
    DPPC-d13

    129Y83-d13

    		 Isotope-Labeled Compounds Endogenous Metabolite Others
    DPPC-d13 is deuterium labeled DPPC. DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in
    DPPC-d13
  • HY-109506S6
    DPPC-d66

    129Y83-d66

    		 Isotope-Labeled Compounds Endogenous Metabolite Others
    DPPC-d66 is deuterium labeled DPPC. DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in
    DPPC-d66
  • HY-109506S7
    DPPC-d71

    129Y83-d71

    		 Isotope-Labeled Compounds Endogenous Metabolite Others
    DPPC-d71 is deuterium labeled DPPC. DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in
    DPPC-d71
  • HY-109506S8
    DPPC-d75

    129Y83-d75

    		 Isotope-Labeled Compounds Endogenous Metabolite Others
    DPPC-d75 is deuterium labeled DPPC. DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in
    DPPC-d75
  • HY-138170A
    ALC-0315 (Excipient)

    		Liposome SARS-CoV Infection
    ALC-0315 Excipient is an ionisable aminolipid that is responsible for mRNA compaction and aids mRNA cellular delivery and its cytoplasmic release through suspected endosomal destabilization. ALC-0315 Excipient can be used to form lipid nanoparticle (LNP) delivery vehicles. Lipid-Nanoparticles have been used in the research of mRNA COVID-19 vaccine .
    ALC-0315 (Excipient)
  • HY-109506S4
    DPPC-d4

    129Y83-d4

    		 Isotope-Labeled Compounds Endogenous Metabolite Others
    DPPC-d4 is deuterium labeled DPPC. DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in m
    DPPC-d4
  • HY-155918
    mPEG-CHO (MW 1000)

    mPEG-Aldehyde (MW 1000)

    		 Biochemical Assay Reagents Others
    mPEG-CHO (MW 1000) participates in the formation of a three-dimensional porous scaffold that carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    mPEG-CHO (MW 1000)
  • HY-B2247A
    PLGA (75:25)

    poly(lactic-co-glycolic acid) (75:25)

    		 Biochemical Assay Reagents Others
    PLGA (75:25) is a low toxicity, biocompatible and biodegradable controlled drug delivery carrier, can achieve slow release in the organism. PLGA (75:25) is a copolymer of 75% poly lactic acid (PLA) and 25% poly glycolic acid (PGA). PLGA (75:25) has been extensively studied as delivery vehicles for agents, proteins and various other macromolecules such as DNA, RNA and peptides .
    PLGA (75:25)
  • HY-155915
    mPEG-CHO (MW 350)

    mPEG-Aldehyde (MW 350)

    		 Biochemical Assay Reagents Others
    mPEG-CHO (MW 350) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    mPEG-CHO (MW 350)
  • HY-155916
    mPEG-CHO (MW 550)

    mPEG-Aldehyde (MW 550)

    		 Biochemical Assay Reagents Others
    mPEG-CHO (MW 550) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    mPEG-CHO (MW 550)
  • HY-155917
    mPEG-CHO (MW 750)

    mPEG-Aldehyde (MW 750)

    		 Biochemical Assay Reagents Others
    mPEG-CHO (MW 750) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    mPEG-CHO (MW 750)
  • HY-155919
    mPEG-CHO (MW 2000)

    mPEG-Aldehyde (MW 2000)

    		 Biochemical Assay Reagents Others
    mPEG-CHO (MW 2000) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    mPEG-CHO (MW 2000)
  • HY-155920
    mPEG-CHO (MW 3400)

    mPEG-Aldehyde (MW 3400)

    		 Biochemical Assay Reagents Others
    mPEG-CHO (MW 3400) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    mPEG-CHO (MW 3400)
  • HY-155921
    mPEG-CHO (MW 5000)

    mPEG-Aldehyde (MW 5000)

    		 Biochemical Assay Reagents Others
    mPEG-CHO (MW 5000) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    mPEG-CHO (MW 5000)
  • HY-155922
    mPEG-CHO (MW 10000)

    mPEG-Aldehyde (MW 10000)

    		 Biochemical Assay Reagents Others
    mPEG-CHO (MW 10000) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    mPEG-CHO (MW 10000)
  • HY-155923
    mPEG-CHO (MW 20000)

    mPEG-Aldehyde (MW 20000)

    		 Biochemical Assay Reagents Others
    mPEG-CHO (MW 20000) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    mPEG-CHO (MW 20000)
  • HY-143692
    SQDG

    		Liposome Metabolic Disease
    SQDG is a glycolipid that possesses sugar moieties in their head groups. SQDG is a membrane lipid that can be used to investigate the effects of structural lipid in LNP formulations .
    SQDG
  • HY-143210
    Transfectam

    		Liposome Metabolic Disease
    Transfectam is a cationic lipid able to interact with DNA to form complexes that mediate efficient gene transfer into various eukaryotic cells .
    Transfectam
  • HY-142985
    Oleyl Mesylate

    		Liposome Metabolic Disease
    Oleyl Mesylate is a derivative of Oleyl Alcohol. Oleyl Alcohol has been incorporated into various formulations for drug delivery .
    Oleyl Mesylate
  • HY-153380
    ALC-0315 analogue-2

    		Liposome Others
    ALC-0315 analogue-2 is an analogue of ALC-0315. ALC-0315 is an ionisable aminolipid that is responsible for mRNA compaction and aids mRNA cellular delivery and its cytoplasmic release through suspected endosomal destabilization. ALC-0315 can be used to form lipid nanoparticle (LNP) delivery vehicles. Lipid-Nanoparticles have been used in the research of mRNA COVID-19 vaccine.
    ALC-0315 analogue-2
  • HY-109506S1
    DPPC-d9

    129Y83-d9

    		 Endogenous Metabolite Others
    DPPC-d9 is the deuterium labeled DPPC. DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers[1]. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in mice[2].
    DPPC-d9
  • HY-109506S
    DPPC-d62

    129Y83-d62

    		 Isotope-Labeled Compounds Endogenous Metabolite Others
    DPPC-d62 is the deuterium labeled DPPC. DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers[1]. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in mice[2].
    DPPC-d62
  • HY-W145518
    Pectin

    		Endogenous Metabolite Bacterial Antibiotic Infection
    Pectin is a heteropolysaccharide, derived from the cell wall of higher plants. Pectin involves in the formation of nanoparticles as a delivery vehicle of agents. Pectin is also an adsorbent, a broad-spectrum antimicrobial agent that binds to bacteria toxins and other irritants in the intestinal mucosa, relieves irritated mucosa .
    Pectin
  • HY-109506S3
    DPPC-d9-1

    129Y83-d9-1

    		 Isotope-Labeled Compounds Endogenous Metabolite Others
    DPPC-d9-1 is the deuterium labeled DPPC. DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers[1]. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in mice[2].
    DPPC-d9-1
  • HY-163977
    Silyl-ether based ROMP Monomer

    2,2-Diphenyl-1,3-dioxa-2-silacyclooct-5-ene

    		 Biochemical Assay Reagents Others
    Silyl-ether based ROMP Monomer (2,2-Diphenyl-1,3-dioxa-2-silacyclooct-5-ene) is a biochemical reagent that can be used in the synthesis of advanced polymer materials for biomedical applications, including drug delivery vehicles and hydrogels .
    Silyl-ether based ROMP Monomer
  • HY-160581
    OH-C-Chol

    		Liposome Others
    OH-C-Chol is a cationic liposome that serves as a siRNA delivery vehicle. OH-C-Chol (LP-C) and OH-NC-Chol (LP-NC)/siRNA complexes (lipoplexes) showed better performance than NP-C and NP-NC/siRNA complexes (nanocomplexes), respectively. ) greater gene silencing effect .
    OH-C-Chol
  • HY-W440883
    DSPE-PEG-Ald, MW 2000

    		Liposome Others
    DSPE-PEG-Ald, MW 2000 is a phospholipid polyPEG which can self-assemble to form lipid bilayer in aqueous solution. The polymer can be used to prepare liposome as a drug delivery vehicle for administration of drugs or nutrients, such as mRNA vaccines. The aldehyde is reactive with aminooxy to form a stable oxime linkage or with amine at pH < 7 to form a reversible imine bond. Reagent grade, for research use only.
    DSPE-PEG-Ald, MW 2000
  • HY-16387
    PF 00337210

    		VEGFR Others
    PF-00337210 is a potent and selective inhibitor of VEGFRs, designed for treating age-related macular degeneration via intravitreal injection. The formulation strategy focused on developing an ophthalmic solution that would precipitate upon injection into the vitreous, ensuring sustained drug delivery. Challenges included maintaining low dosing volumes, selecting safe excipients for intravitreal use, and addressing the drug's unique physicochemical properties. The final formulation, an isotonic solution in a citrate-buffered vehicle with NaCl, demonstrated stability, potency, and recovery through intravitreal dosing syringes. It formed a depot upon injection into vitreous humor, representing a novel nonpolymeric in situ-forming depot formulation for intravitreal drug delivery .
    PF 00337210
  • HY-106031
    F-14512

    		Others Cancer
    F-14512 is a targeted cytotoxic compound that utilizes the polyamine transport system (PTS) to selectively deliver polyamine-containing drugs to cancer cells. F-14512 combines an epipodophyllotoxin core that targets topoisomerase II with a spermine group that acts as a cell delivery vehicle, with improved selectivity for tumor cells. F-14512 exhibits significant cytotoxicity against cells with high PTS activity and demonstrates high potency in multiple human cell lines (median IC50=0.18 μM). In the MX1 breast tumor xenograft model, F-14512 exhibits potent antitumor activity .
    F-14512

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: